DL-Carnitine → (-)-Carnitine

HRID 64789

Reaktionsgleichung

Reaktionsgleichung von HRID 64789
[CH3:1][N+:2]([CH2:5][CH:6]([OH:11])[CH2:7][C:8]([O-:10])=[O:9])([CH3:4])[CH3:3].C([C@@](C(O)=O)(O)[C@@](C(=O)C1C=CC=CC=1)(O)C(O)=O)(=O)C1C=CC=CC=1>>[OH:11][C@@H:6]([CH2:7][C:8](=[O:9])[O-:10])[CH2:5][N+:2]([CH3:4])([CH3:1])[CH3:3].[OH:11][C@H:6]([CH2:7][C:8](=[O:9])[O-:10])[CH2:5][N+:2]([CH3:4])([CH3:1])[CH3:3]

Komponenten

4

Edukt 2

HCID 288DL-CarnitineHCID 12362976dibenzoyl-L(+)tartaric acid

Produkt 2

HCID 10917(-)-CarnitineHCID 2724480D-Carnitine

Versuchsvorschrift

According to a preferred embodiment of the present invention, in the first step, to DL-carnitine is added dibenzoyl-L(+)tartaric acid and a lower alcohol, the mixture is dissolved under heat to form dibenzoyl-L(+)tartarates of D-carnitine and L-carnitine, and subsequently the tartarates are cooled to fractionally crystallize dibenzoyl-L(+)tartarate of L-carnitine.

Aufarbeitung

  1. temperatureunder heat

Quellen und Nachweise

ORD-Eintrag
ord-ed9fbd3112d74974ab4102dc6525a18f
Quelldatensatz
uspto-grants-1986_09
Patentnummer
US04610828

Verknüpfte Notizen

Wird geladen…